Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
NRXP — NRx Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 24, 2026
REVENUE
$983000 +306.2%
NET MARGIN
36.6% +2470.5 PTS
EPS
$0.01 +104.2%
FREE CASH FLOW
-$3.7M -28.4%

No summary has been written for this call yet.